Graham Capital Management L.P. Makes New $276,000 Investment in Grail, Inc. (NASDAQ:GRAL)

Graham Capital Management L.P. purchased a new stake in shares of Grail, Inc. (NASDAQ:GRAL - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 15,447 shares of the company's stock, valued at approximately $276,000.

Several other institutional investors have also added to or reduced their stakes in the company. Lindbrook Capital LLC purchased a new stake in shares of Grail during the 4th quarter worth approximately $28,000. State of Tennessee Department of Treasury bought a new stake in Grail in the fourth quarter worth $28,000. Sterling Capital Management LLC purchased a new stake in Grail during the fourth quarter valued at $29,000. Wellington Shields Capital Management LLC bought a new position in Grail during the fourth quarter valued at $33,000. Finally, Public Employees Retirement Association of Colorado bought a new position in Grail during the fourth quarter valued at $50,000.

Grail Price Performance

Shares of GRAL traded down $1.86 during midday trading on Wednesday, hitting $37.46. The stock had a trading volume of 1,000,858 shares, compared to its average volume of 1,256,693. The stock's 50 day moving average is $30.41 and its 200 day moving average is $27.00. The firm has a market cap of $1.35 billion and a PE ratio of -0.61. Grail, Inc. has a 1 year low of $12.33 and a 1 year high of $63.99.

Grail (NASDAQ:GRAL - Get Free Report) last issued its quarterly earnings results on Tuesday, May 13th. The company reported ($3.10) EPS for the quarter, beating the consensus estimate of ($4.03) by $0.93. The firm had revenue of $31.84 million for the quarter, compared to the consensus estimate of $35.80 million. As a group, equities research analysts expect that Grail, Inc. will post -15.15 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on GRAL shares. Canaccord Genuity Group upped their target price on shares of Grail from $32.00 to $43.00 and gave the company a "buy" rating in a research report on Wednesday, May 14th. Morgan Stanley upped their price objective on Grail from $16.00 to $20.00 and gave the company an "equal weight" rating in a research report on Tuesday, March 18th.

Insider Buying and Selling at Grail

In other Grail news, CFO Aaron Freidin sold 1,816 shares of the stock in a transaction on Friday, March 7th. The stock was sold at an average price of $31.20, for a total value of $56,659.20. Following the sale, the chief financial officer now owns 335,170 shares in the company, valued at $10,457,304. This trade represents a 0.54% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, President Joshua J. Ofman sold 2,109 shares of Grail stock in a transaction on Friday, March 7th. The stock was sold at an average price of $31.20, for a total value of $65,800.80. Following the sale, the president now owns 559,673 shares of the company's stock, valued at approximately $17,461,797.60. This trade represents a 0.38% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 194,948 shares of company stock worth $6,583,130 over the last 90 days. Company insiders own 1.85% of the company's stock.

Grail Company Profile

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.